Table 1

Study characteristics

First author, ref	Study period	Country	Study design	Patients (n)	Initial stroke severity (mean NIHSS)	IV rtPA (%)	Recanalization (%)	Favorable outcome (mRS≤2) (%)	SICH (%)	Mortality, delay	Time to recanalization (h)
Singer et al22	2011–2013	Germany, Austria	R, multicenter	148	20	–	79	34	5.4	35%, 3 months	–
Gory et al13	2010–2014	Ireland	R, single center	22	–	–	–	–	–	–	–
Son et al23	2011–2013	Korea	R, single center	31	23.8	45.2	94	41.9	0	9.7%, discharge, further 9.7%, 3 months	–
Mourand et al18	2009–2011	France	R, single center	31	14	61	74	35	16	32%, 3 months	8.5
Mohlenbruch et al16	2009–2012	Germany	R, single center	24	24	87	75	33	4	29%, 3 months	5.5
Lefevre et al14	2010–2012	France	R, single center	25	20.3	–	92	56	4	40%, 3 months	–
Fesl et al12	2001–2011	Germany	R, single center	11	–	11	82	36	0	36%, discharge	–
Baek et al1	2010–2012	Korea	P, single center	25	11	24	96	48	0	12%, 3 months	5.1
Raoult et al21	2010–2012	France	P, single center	12	18.8	17	100	58	8	25%, discharge	7.8
Park et al20	2012–2013	Korea	R, single center	16	12.2	25	44	56	0	6%, 3 months	7.4
Nagel et al19	1998–2012	Germany	P, single center	36	–	64	83	31	3	36%, 3 months	–
Mordasini et al17	2010–2011	Switzerland	P, single center	14	21	36	79	29	0	36%, discharge	7.6
Espinosa de Rueda et al4	2010–2012	Spain	R, single center	18	20.4	–	94	50	0	22%, discharge	7.3
Andersson et al11	2005–2010	Sweden	R, single center	28	–	–	64	57	0	21%, 3 months	–
Dorn et al3	2008–2009	Germany	R, single center	24	16.1	–	71	–	–	46%, discharge	–
Miteff et al15	2009–2010	Australia	R, single center	10	26.3	0	100	20	10	30%, discharge	13.6
Costalat et al2	2008–2010	France	P, single center	16	–	62	81	44	6	25%, 3 months	9.3

mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; P, prospective; R, retrospective; rtPA, recombinant tissue plasminogen activator; SICH, symptomatic intracranial hemorrhage.